What's at stake: Many medicinal cannabis companies need to raise more money while they slowly build revenue but investor sentiment has waned.
Background: Cannasouth's voluntary administration has spooked the investor market at a time when many medicinal cannabis companies are trying to raise more funds. Cannasouth's predicament comes as the government moves to finally make changes to stringent exporting requirements that could bolster revenue.
Main players: Cannasouth, NZ Medicinal Cannabis Council, Ministry of Health, government, Puro, Rua Biosciences, Greenfern, Nubu, Helius Therapeutics.
The day it was announced to the stock exchange that listed medicinal cannabis company Cannasouth was going into voluntary administration, the industry says it received news Health Minister Shane Reti had given the thumbs up to regulatory changes to go to Cabinet that would remove a big export
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
What's at stake: Many medicinal cannabis companies need to raise more money while they slowly build revenue but investor sentiment has waned.
Background: Cannasouth's voluntary administration has spooked the investor market at a time when many medicinal cannabis companies are trying to raise more funds. Cannasouth's predicament comes as the government moves to finally make changes to stringent exporting requirements that could bolster revenue.
Main players: Cannasouth, NZ Medicinal Cannabis Council, Ministry of Health, government, Puro, Rua Biosciences, Greenfern, Nubu, Helius Therapeutics.
